Clinical trial
The Role of Peptide-loaded Dendritic Cells to Augment the Therapeutic Effect of…
NCT00279058 · Hadassah Medical Organization, Other · Completed
Key facts
| NCT number | NCT00279058 |
|---|---|
| Title | The Role of Peptide-loaded Dendritic Cells to Augment the Therapeutic Effect of Interleukin-2 |
| Official title | The Role of Autologous Dendritic Cells Pulsed by Melanoma Associated Peptides to Augment the Therapeutic Effect of Interleukin-2 |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Melanoma |
| Intervention type | Procedure |
| Interventions | Immunotherapy treatment for melanoma |
| Enrollment | 24 |
| Start date | Dec 1, 2005 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jan 19, 2006 |
| Last update posted | Apr 21, 2015 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: